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Safety, Hemodynamic Profile, and Feasibility of
Dobutamine Stress Technetium Myocardial Perfusion
Single-Photon Emission CT Imaging for Evaluation of
Coronary Artery Disease in the Elderly*
Abdou Elhendy, MD, PhD; Ron T. van Domburg, PhD; Jeroen J. Bax, MD, PhD;
Roelf Valkema, MD, PhD; Ambroos E. M. Reijs, MSc;
Eric P. Krenning, MD, PhD; and Jos R. T. C. Roelandt, MD, PhD
Objectives: Cardiovascular disease is the leading cause of morbidity and mortality in the elderly.
The evaluation of coronary artery disease by exercise stress testing is frequently limited by the
patient’s inability to exercise. Although pharmacologic stress testing with dobutamine is an
alternative, the safety of dobutamine myocardial perfusion scintigraphy in the elderly has not
been previously studied.
Patients and methods: We studied the safety and feasibility of dobutamine (up to 40 mg/kg/min)-
atropine (up to 1 mg) stress myocardial perfusion scintigraphy using technetium single-photon
emission CT imaging in 227 patients > 70 years old (mean 6 SD age, 75 6 4 years). A control
group of 227 patients < 70 years old (mean age, 55 6 11 years; matched for gender, prevalence
of previous infarction, b-blocker therapy, and severity of resting perfusion abnormalities) was
studied to assess age-related differences in the safety and the hemodynamic response. A feasible
test was defined as the achievement of the target heart rate and/or an ischemic end point (angina,
ST-segment depression, or reversible perfusion abnormalities).
Results: No myocardial infarction or death occurred during the test. The target heart rate was
achieved more frequently in the elderly patients (87% vs 79%; p < 0.05). The elderly patients had
a higher prevalence of supraventricular tachycardia (7% vs 1%; p < 0.005) and premature
ventricular contraction (74% vs 32%; p < 0.005) during the test, as compared to the younger
patients. There was a trend to a higher prevalence of ventricular tachycardia (5% vs 2%) and
atrial fibrillation (3% vs 0.4%) in the elderly patients. Arrhythmias were terminated spontane-
ously by termination of dobutamine infusion or by administration of metoprolol. Independent
predictors of supraventricular tachyarrhythmias and ventricular tachycardia were older age
(p < 0.001; x2, 9.8) and myocardial perfusion defect score at rest (p < 0.01; x2, 6.8) respectively,
by using a multivariate analysis of clinical and stress test variables. Elderly patients had a higher
prevalence of systolic BP drop > 20 mm Hg during the test (37% vs 12%; p < 0.05). The test was
terminated due to hypotension in 2% of the elderly patients and in 1% of the control group. Age
was the most powerful predictor of hypotension (p < 0.005; x2, 10.3). The test was considered
feasible in 216 elderly patients (95%) and in 209 patients of the control group (92%).
Conclusion: Dobutamine-atropine stress myocardial perfusion scintigraphy is a highly feasible
method for the evaluation of coronary artery disease in the elderly. Elderly patients have a higher
risk for developing hypotension and supraventricular tachyarrhythmias during a dobutamine
stress test. However, dobutamine-induced hypotension is often asymptomatic and rarely neces-
sitates the termination of the test. (CHEST 2000; 117:649–656)
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C ardiovascular disease is the leading cause ofmorbidity and mortality in the elderly popula-
tion.1,2 Recent advances in revascularization proce-
dures have led to an increase in the number of
elderly patients undergoing coronary artery bypass
grafting or coronary angioplasty, with a clear benefit
on short-term and long-term survival.1,4 Therefore,
stress testing is justified for the diagnosis and func-
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tional evaluation of coronary artery disease in this
population to select patients who are candidates for
further interventions. Exercise stress testing is the
most widely used noninvasive method for evaluation
of coronary artery disease.5 However, a larger pro-
portion of the elderly population may be unable to
perform exercise stress test due to the higher prev-
alence of pulmonary airway, degenerative joint, and
peripheral vascular diseases, and the reduced phys-
ical fitness in the elderly as compared to the younger
population.1,6 Pharmacologic stress testing in con-
junction with myocardial perfusion imaging is an
established method for the evaluation of coronary
artery disease in patients with limited exercise capac-
ity.7–13 Dobutamine perfusion imaging is a feasible
method particularly in patients with obstructive air-
way disease who are not candidates for a vasodilator
stress test.9–13 Numerous studies have reported the
safety of dobutamine stress echocardiography14,15
and myocardial perfusion scintigraphy.9,10 However,
the safety of dobutamine perfusion imaging in the
elderly has not been reported. Elderly patients are at
a higher risk for developing spontaneous and exer-
cise-induced arrhythmias,16,17 as well as impairment
of compensatory mechanisms for hypotension.
Therefore, these patients may be more vulnerable to
hypotension and arrhythmias during a dobutamine
stress test. The aims of this study are as follows: (1)
to assess the safety, feasibility, and hemodynamic
profile of dobutamine stress myocardial perfusion
scintigraphy in the elderly population with limited
exercise capacity who are referred for the diagnosis
or functional evaluation of coronary artery disease;
and (2) to assess the age-specific differences in the
safety and hemodynamic profile by comparing these
parameters in the elderly with a control group of
younger patients matched for the major clinical
characteristics that might influence the safety and
feasibility of the test.
Materials and Methods
Patient Population
Study population comprised 227 elderly patients $ 70 years
old with limited exercise capacity who were referred for evalua-
tion of myocardial ischemia by dobutamine stress-technetium
myocardial perfusion scintigraphy between January 1994 and
January 1999 in our imaging laboratory. A group of 227 patients
, 70 years old matched for gender, medication with b blockers,
previous myocardial infarction, and fixed myocardial perfusion
defect score served as control subjects. The test was not per-
formed in patients with severe heart failure, significant valvular
heart disease, severe hypertension (BP $ 180/110 mm Hg),
hypotension (BP , 90/60 mm Hg), and unstable chest pain. All
patients gave verbal informed consent to undergo the study. The
Hospital Ethical Committee approved the use of the dobutamine
stress test for evaluation of coronary artery disease.
Clinical Features: The clinical characteristics of patients $ 70
years and , 70 years old are summarized in Table 1. There was
no significant difference between both groups regarding the
prevalence of hypertension, diabetes mellitus, cigarette smoking,
previous revascularization, medications at the day of the test, or
indications of stress testing. Hypercholesterolemia was more
prevalent in the younger group.
Dobutamine Stress Test
Dobutamine was infused through the antecubital vein starting
at a dosage of 5 mg/kg/min followed by 10 mg/kg/min (3-min
stages), increasing by 10 mg/kg/min every 3 min to a maximum of
40 mg/kg/min. Atropine (up to 1 mg) was given to patients who
did not achieve 85% of maximal heart rate predicted for age and
gender (220 2 age [in years] beats/min in men and 200 2 age
beats/min in women) and dobutamine infusion was continued.
The ECG was monitored throughout dobutamine infusion and
was recorded every minute. Cuff BP was measured at rest, every
3 min during stress, and at maximal stress. The test was inter-
rupted if severe chest pain, horizontal or downsloping ST-
segment depression . 2 mm, ventricular or supraventricular
tachycardia consisting of $ 10 complexes, hypertension (BP
$ 240/120 mm Hg), systolic BP fall . 40 mm Hg, or any
intolerable side effect regarded as being due to dobutamine
occurred during the test. IV metoprolol (from 1 to 5 mg) was
used to reverse the effects of dobutamine if these did not revert
quickly.
Single-Photon Emission CT Imaging
Approximately 1 min before the termination of the stress test,
IV 99mtechnetium sestamibi, 370 MBq, (in 230 patients) or
Table 1—Clinical Features of Patients > 70 and < 70






(n 5 227) p Value
Age, yr 75 6 4 55 6 11 0.00001
Men† 112 (49) 112 (49) 1
Previous MI† 81 (36) 81 (36) 1
Previous CABG 36 (16) 38 (17) 0.9
Previous PTCA 33 (15) 36 (16) 0.8
History of hypertension 107 (47) 100 (44) 0.6
Diabetes mellitus 34 (15) 38 (17) 0.7
Cigarette smoking 44 (19) 59 (26) 0.1
Hypercholesterolemia 56 (25) 79 (35) 0.02
Medications
b blockers† 98 (43) 98 (43) 1
Calcium channel blockers 106 (47) 94 (41) 0.3
ACE inhibitors 67 (30) 66 (29) 1
Indications for stress testing
Typical chest pain 76 (33) 70 (31) 0.6
Atypical chest pain 81 (36) 69 (30) 0.3
Exertional dyspnea or fatigue 22 (10) 25 (11) 0.8
Assessment after MI or after
revascularization
48 (21) 63 (28) 0.1
*Data are presented as mean 6 SD or as No. (%); MI 5 myocardial
infarction; CABG 5 coronary artery bypass graft surgery;
PTCA 5 percutaneous transluminal coronary angioplasty;
ACE 5 angiotensin-converting enzymes.
†The two groups were matched for these parameters.
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tetrofosmin (in 224 patients) was administered. The acquisition
of stress single-photon emission CT imaging was started 1 h after
the test. Resting studies were performed 24 h after the stress
study and 1 h after injection of 370 MBq of sestamibi or
tetrofosmin. The same isotope administered during stress was
used for rest studies. An equal number of patients in each group
received the same tracer. Image acquisition and interpretation
were performed according to the previously described proto-
cols.10 For each study, six oblique (short-axis) slices from the apex
to the base and three sagittal (vertical long-axis) slices from the
septum to the lateral wall were defined. Each of the six short-axis
slices were divided into eight equal segments. The interpretation
of the scan was performed using visual analysis assisted by the
circumferential profiles analysis. Stress and rest tomographic
views were reviewed in side-by-side pairs by an experienced
observer who was unaware of the patients’ clinical data. A
reversible perfusion defect was defined as a perfusion defect on
stress images that partially or completely resolved at-rest images
in two or more contiguous segments or slices. This was consid-
ered diagnostic of ischemia. A fixed perfusion defect was defined
as a perfusion defect on stress images in two or more contiguous
segments or slices that persisted on rest images. Six major
myocardial segments were identified: anterior, inferior, septal
anterior, septal posterior, posterolateral, and apical. To assess the
severity of perfusion abnormalities, each of the six major left
ventricular segments was scored using a 4-grade scoring method
(0 5 normal, 1 5 slightly reduced, 2 5 moderately reduced, and
3 5 severely reduced or absent uptake). The perfusion score was
derived using the summation of the scores of the six myocardial
segments for rest and stress images. Ischemic score was obtained
by subtracting the rest score from the stress score. The rest score
(fixed perfusion defect) was considered as the infarction score.10
A dobutamine stress test was considered feasible if the patient
could achieve 85% of the maximal heart rate predicted for age
and/or when an ischemic end point (angina, ST-segment depres-
sion, reversible perfusion abnormalities) was reached.
Statistical Analysis
Unless specified, data are presented as mean values 6 SD. The
x2 test was used to compare differences between proportions.
The Student’s t test was used for analysis of continuous data.
Stepwise logistic regression models were used to identify inde-
pendent predictors of hypotension and arrhythmias. Differences
were considered significant if the null hypothesis could be
rejected at the 0.05 probability level.
Results
Hemodynamic Response
Table 2 summarizes the hemodynamic and dobut-
amine stress test variables in both groups. Heart rate
increased significantly from rest to peak stress in
both groups (p , 0.0001). Systolic BP increased
significantly in the younger group (p , 0.0001), but
not in the elderly group. Diastolic BP dropped more
significantly from rest to peak stress in the elderly
patients compared to the younger patients
(p , 0.05). Elderly patients had a higher baseline
systolic BP, a lower peak heart rate, a lower peak rate
pressure product, and a higher prevalence of systolic
BP drop . 20 mm Hg. There was no significant
difference between both groups regarding the max-
imal dobutamine dose, frequency of atropine admin-
istration, incidence of ST-segment depression, an-
gina, symptomatic hypotension, and minor side
effects during the test (Table 3).
The prevalence of various types of arrhythmias
during the test is shown in Figure 1. Ventricular and
supraventricular tachycardia were terminated in all
cases spontaneously by stopping dobutamine infu-
sion or by administration of metoprolol. Ventricular
tachycardia consisting of $ 10 beats occurred in two
patients (one patient in each group). Elderly patients
had a significantly higher prevalence of supraventric-
ular tachycardia and premature ventricular contrac-
tions and a trend to a higher prevalence of atrial
fibrillation (p 5 0.1) and ventricular tachycardia
(p 5 0.2), compared to the younger patients.
Table 2—Hemodynamic Data of Patients > 70 and < 70 Years Old Undergoing Dobutamine-Atropine Stress
Myocardial Perfusion Scintigraphy*




(n 5 227) p Value
Heart rate at rest, beats/min 71 6 14 74 6 15 0.1
Heart rate at peak stress, beats/min 126 6 15 136 6 16 0.0001
Systolic BP at rest, mm Hg 147 6 24 137 6 23 0.0001
Systolic BP at peak stress, mm Hg 147 6 31 147 6 29 0.8
Diastolic BP at rest, mm Hg 78 6 12 79 6 13 0.4
Diastolic BP at peak stress, mm Hg 72 6 15 76 6 17 0.01
Rate pressure product at rest 10,522 6 2,913 9,521 6 2,412 0.2
Rate pressure product at peak stress 18,510 6 4,284 19,953 6 4,454 0.0007
Systolic BP drop . 20 mm Hg, patients 48 (21) 27 (12) 0.01
Systolic BP drop . 40 mm Hg, patients 10 (4) 5 (2) 0.2
Maximal dobutamine dose, mg/kg/min 35.3 6 7.6 36.4 6 7.2 0.1
Atropine given, patients 82 (36) 94 (41) 0.3
Mean atropine, dose, mg 0.5 6 0.3 0.6 6 0.3 0.004
Horizontal or downsloping ST depression, patients 53 (23) 37 (16) 0.3
*Data are presented as mean 6 SD or No. (%).
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Test End Points
The reasons for termination of the test in both
groups are listed in Table 4. The test was terminated
because of reaching the target heart rate more
frequently in the elderly group. The test was termi-
nated due to angina, ST-segment changes, arrhyth-
mias, hypotension, hypertension, and other minor
side effects in a similar proportion of both groups,
whereas the younger patients had a higher rate of
failure to reach the target heart rate, despite the
maximal dose of dobutamine and atropine. Nineteen
elderly patients and 34 of the younger patients could
not achieve the target heart rate and had no angina
or ST-segment depression. Reversible perfusion de-
fects were detected in 8 and 16 of these patients,
respectively, resulting in a feasible test (achievement
of the target heart rate or an ischemic end point) in
216 elderly patients (95%) and in 209 of the younger
patients (92%).
Myocardial Perfusion Scintigraphy
The prevalence of different perfusion scinti-
graphic patterns in both groups is shown in Figure 2.
There was no significant difference between both
groups regarding the prevalence of reversible or
fixed perfusion defects.
Gender Differences
Women had a higher prevalence of normal myo-
cardial perfusion (56% vs 23%; p , 0.001), a lower
infarction score (1.1 6 2.2 vs 3 6 3; p , 0.0001),
and a lower ischemic score (0.8 6 1.7 vs 1.6 6 2.4;
p , 0.0001) compared to men, respectively. There
was no significant difference regarding the stress rate
pressure product between men and women in the
elderly group (18,707 6 4,508 vs 18,304 6 4,027) or
in the younger group (19,967 6 4,223 vs 19,940 6
4,810), respectively.
Sestamibi vs Tetrofosmin Studies
Patients who underwent sestamibi imaging had a
higher ischemic score than patients who underwent
tetrofosmin imaging (1.4 6 2.1 vs 0.8 6 1.5;
p , 0.005). The infarction score was not significantly
different between both groups (2.1 6 2.7 vs
1.9 6 2.8, respectively; p 5 0.4)
Predictors of Hypotension and Arrhythmias
Clinical and stress test variables included in the
multivariate analysis model were as follows: age,
gender, history of angina, previous myocardial in-
farction, hypertension, baseline systolic BP, medica-
tions, maximal dobutamine dose, peak heart rate,
abnormal perfusion, fixed and ischemic perfusion
defect scores, and angina during the test. Indepen-
dent predictors of systolic BP drop . 20 mm Hg
during stress were older age (p , 0.005; x2, 10.3), a
higher stress heart rate (p , 0.01; x2, 7.7), a higher
baseline systolic BP (p , 0.05; x2, 5.1), medication
with calcium antagonists (p , 0.05; x2, 4.1), and a
higher dobutamine dose (p , 0.05; x2, 4.7). The only
independent predictor of supraventricular tachyar-
rhythmias (supraventricular tachycardia and atrial
fibrillation) was older age (p , 0.001; x2, 9.8). The
infarction (rest perfusion defect) score was the only
independent predictor of ventricular tachycardia
(p , 0.01; x2, 6.8).
Discussion
As far as we are concerned, this is the first study
that evaluates the safety and feasibility of dobut-
amine stress myocardial perfusion scintigraphy in the
elderly. The mean age of the elderly patients in our
study was 75 years. These patients represented the
usual candidates for pharmacologic stress testing at
this age group who are unable to perform an exercise
stress test. Referring patients at this age for the
noninvasive evaluation of coronary artery disease
reflects the confidence of physicians regarding the
beneficial effects of guided therapeutic interventions
in the elderly. A group of younger patients was used
as a control group in this study. The patients were
matched for the major clinical features that may have
an influence on the hemodynamic profile and the
safety of the test. The patients were matched for
gender because previous studies have shown gender-
related difference in the chronotropic response and
safety.18,19 The severity of resting perfusion abnor-
malities (and presumably left ventricular dysfunc-
tion) was also selected among matching parameters
because the extent of myocardial perfusion abnor-
malities was reported to predict complications dur-
Table 3—Symptoms of Patients > 70 and < 70 Years






(n 5 227) p Value
Nausea 6 (3) 13 (6) 0.2
Flushing 0 (0) 1 (0.4) 0.1
Dizziness 10 (4) 5 (2) 0.3
Anxiety 4 (2) 6 (3) 0.7
Chills 17 (7) 13 (6) 0.6
Headache 15 (7) 11 (5) 0.5
Symptomatic hypotension 4 (2) 2 (1) 0.7
Typical angina 68 (30) 52 (23) 0.1
*Data are presented as No. (%).
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ing the test.10 Finally, the patients were matched for
the treatment with b blockers because these agents
interfere with the chronotropic response to dobut-
amine and therefore may reduce the feasibility of the
test, increase the need for atropine administration,
or reduce the prevalence and severity of inducible
ischemia.20 On the other hand, the intake of b
blockers may be associated with more complications,
presumably because these medications are pre-
scribed to patients with a higher risk profile, as are
patients with previous myocardial infarction, typical
angina, and hypertension.19 Therefore, matching the
two groups allowed an independent detection of any
possible age-specific difference in the hemodynamic
and safety profile of the dobutamine stress test. This
matching explains the nearly similar clinical features
of the two groups of patients, as shown in Table 1.
Our study demonstrated that dobutamine myocar-
dial perfusion scintigraphy is a highly feasible
method for the noninvasive evaluation of coronary
artery disease in the elderly. Ninety-five percent of
these patients could achieve the end point of target
heart rate and/or an ischemic end point.
Heart Rate Response: A higher proportion of the
elderly patients could achieve the target heart rate.
This may be related to a higher dose-related re-
sponse due to age-related changes in the pharmaco-
kinetics of the drugs. Another explanation is the
lower calculated target heart rate in the elderly that
renders the achievement of the target heart rate
easier in older patients.5 This can also explain the
lower peak heart rate in the elderly. Despite the fact
that previous studies have demonstrated that elderly
subjects have a reduced sensitivity to sympathetic
stimulation,21 it has been recently shown that the
cardiac chronotropic response to b-receptor adren-
ergic stimulation is not reduced in the elderly.22
BP Response: Systolic BP increased significantly
from rest to peak stress in the younger patients but
not in the elderly patients. Diastolic BP dropped
more significantly from rest to peak stress in the
elderly patients compared to the younger patients.
Additionally, the prevalence of hypotension during
the test was significantly higher in the elderly pa-
Figure 1. The prevalence of various types of arrhythmias during dobutamine stress test in patients
$ 70 years old and , 70 years old. y 5 years old; PACs 5 premature atrial contractions;
PVCs 5 premature ventricular contractions; SVT 5 supraventricular tachycardia; AF 5 atrial fibrilla-
tion; VT 5 ventricular tachycardia.
Table 4—Reasons for Termination of Dobutamine
Stress Testing in Patients > 70 and < 70 Years Old*




(n 5 227) p Value
85% of maximal heart rate 197 (87) 180 (79) 0.045
Maximal dose 8 (4) 29 (13) 0.001
Angina 7 (3) 9 (4) 0.8
ST changes 4 (2) 4 (2) 1
Arrhythmias 3 (1.3) 1 (0.4) 0.6
Hypertension 2 (0.9) 1 (0.4) 0.7
Hypotension 5 (2) 2 (1) 0.3
Chills, flushing, anxiety, dizziness 1 (0.4) 1 (0.4) 1
*Data are presented as No. (%).
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tients. However, most of the episodes of hypotension
were asymptomatic, and the test was terminated
because of hypotension only in five patients (2%).
The test was terminated because of marked systolic
BP increase in two elderly patients and in one
younger patient. The impairment of systolic BP
response to dobutamine in the elderly patients may
be explained by different mechanisms. These in-
clude the impairment of compensatory mechanism
for hypotension with aging,23 rendering the patients
susceptible to hypotension induced by the action of
dobutamine on b2 receptors with subsequent pe-
ripheral vasodilation. It has also been demonstrated
that elderly subjects maintain cardiac output during
exercise by an increase in the end-diastolic dimen-
sion.24 Since dobutamine infusion causes a signifi-
cant reduction of the end-diastolic dimension,25,26
this may deprive the subject from this compensatory
mechanism. Peripheral vasodilatation induced by
dobutamine may further compromise diastolic filling
of the left ventricle. This contention is supported by
our finding that dobutamine dose and medication
with calcium channel blockers were independent
predictors of hypotension during the test. Finally,
the elderly had higher baseline systolic BP compared
to the younger patients. A higher baseline systolic BP
was reported to predict hypotension during dobut-
amine stress test.14,19 In this study, both the age and
the baseline systolic BP were independently associ-
ated with dobutamine-induced hypotension, which
demonstrates that the higher baseline systolic BP in
the elderly was contributing (but was not the sole
underlying mechanism) to dobutamine-induced hy-
potension in the elderly.
Arrhythmias: Elderly patients had a higher prev-
alence of supraventricular tachycardia (7% vs 1%),
atrial fibrillation (3% vs 0.4%), and premature ven-
tricular contraction (74% vs 32%) during the test
compared to the younger patients. There was also a
trend to a higher prevalence of ventricular tachycar-
dia in the elderly (5% vs 2%). However, the tachy-
cardia was terminated spontaneously by termination
of dobutamine infusion or by administration of meto-
prolol. No myocardial infarction or death occurred in
any patient. The test was terminated because of
arrhythmias in four patients (three in the elderly and
one in the younger patients). Age was an indepen-
dent predictor of supraventricular tachyarrhythmias.
Previous studies have demonstrated an increased
prevalence of spontaneous and exercise-induced ar-
rhythmias with aging,16,17 which might explain the
higher prevalence of tachyarrhythmias (particularly
supraventricular tachycardia and premature ventric-
ular contractions) in the elderly patients in this study.
A trend was found to a higher prevalence of ventric-
ular tachycardia in the elderly. However, the severity
of resting perfusion abnormalities (and, presumably,
resting left ventricular dysfunction) was the only
independent predictor of the occurrence of ventric-
ular tachycardia. This may be explained by the
higher probability of the presence of substrate for
Figure 2. The prevalence of myocardial perfusion abnormalities in patients $ 70 years old and , 70
years old undergoing dobutamine stress test. PD 5 perfusion defect; see Figure 1 for abbreviation.
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arrhythmias in patients with more severe left ven-
tricular dysfunction.10
Studies of Dobutamine Stress Echocardiography
in the Elderly: Few reports are available regarding
the safety of dobutamine stress echocardiography in
the elderly. These studies included smaller numbers
of patients compared to our study and did not
compare the results with a control group,27–29 or
compared the elderly with a younger population
unmatched for clinical variables that may influence
the safety and feasibility of the dobutamine stress
test.19 Poldermans et al27 studied 179 patients $ 70
years old by dobutamine-atropine stress echocardi-
ography. Arrhythmias induced during the test were
atrial fibrillation in 2%, nonsustained ventricular
tachycardia in 2%, and premature ventricular con-
tractions in 21%. Hypotension occurred in 4%. No
control group was studied. Baudhuin et al28 studied
63 patients $ 60 years old compared to 63 patients
, 60 years old by dobutamine stress echocardiogra-
phy. Sensitivity and specificity of dobutamine echo-
cardiography for the diagnosis of coronary artery
disease were 80% and 75% in the older patients and
79% and 88% in the younger patients, respectively.
The prevalence of minor side effects was similar in
both groups. Hiro et al19 studied 106 patients $ 75
years old by dobutamine stress echocardiography.
Elderly patients had a higher prevalence of symp-
tomatic hypotension and ventricular arrhythmias and
a similar prevalence of supraventricular arrhythmias
as compared to the younger patients. In their study,
age was an independent predictor of hypotension but
not of arrhythmias. However, the prevalence of
different types of supraventricular or ventricular
arrhythmias was not reported. Anthopoulos et al29
studied 120 elderly patients who underwent coro-
nary angiography by dobutamine echocardiography.
Sensitivity, specificity, and accuracy of dobutamine
echocardiography for the diagnosis of coronary ar-
tery disease were 86.5%, 84%, and 86%, respec-
tively. Although the use of echocardiographic imag-
ing during dobutamine infusion was shown in
previous studies to have a reasonable accuracy for
the detection of coronary artery disease in the
elderly, this study shows that myocardial perfusion
imaging is a feasible alternative and should be
considered, particularly in centers without adequate
experience in stress echocardiographic imaging.
Clinical Implications and Conclusion: Dobut-
amine-atropine stress myocardial perfusion scintig-
raphy is a highly feasible method for the evaluation
of coronary artery disease in the elderly. The target
heart rate is achieved more frequently during the
test in elderly patients than in younger patients.
Elderly patients are at increased risk for developing
supraventricular tachyarrhythmias during a dobut-
amine stress test. Although dobutamine-induced hy-
potension is more frequent in elderly patients, it is
often asymptomatic and rarely necessitates termina-
tion of the test.
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